You are here

Article info

Article menu
Review
Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps

Authors

  • Ola Bratt Department of Urology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska Academy, Goteborg, SwedenDepartment of Urology, Sahlgrenska University Hospital, Goteborg, Sweden PubMed articlesGoogle scholar articles
  • Anssi Auvinen Health Sciences, Faculty of Social Sciences, Tampere University, Tampere, Pirkanmaa, Finland PubMed articlesGoogle scholar articles
  • Rebecka Arnsrud Godtman Department of Urology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska Academy, Goteborg, SwedenDepartment of Urology, Sahlgrenska University Hospital, Goteborg, Sweden PubMed articlesGoogle scholar articles
  • Mikael Hellström Department of Radiology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska Academy, Goteborg, SwedenDepartment of Radiology, Sahlgrenska University Hospital, Goteborg, Sweden PubMed articlesGoogle scholar articles
  • Jonas Hugosson Department of Urology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska Academy, Goteborg, SwedenDepartment of Urology, Sahlgrenska University Hospital, Goteborg, Sweden PubMed articlesGoogle scholar articles
  • Hans Lilja Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USADepartment of Translational Medicine, Lund University Faculty of Medicine, Malmö, Sweden PubMed articlesGoogle scholar articles
  • Jonas Wallström Department of Radiology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska Academy, Goteborg, SwedenDepartment of Radiology, Sahlgrenska University Hospital, Goteborg, Sweden PubMed articlesGoogle scholar articles
  • Monique J Roobol Department of Urology, Cancer Institute, Erasmus University Rotterdam, Rotterdam, Zuid-Holland, Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Ola Bratt; ola.bratt{at}gu.se
View Full Text

Citation

Bratt O, Auvinen A, Arnsrud Godtman R, et al
Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps
BMJ Oncology 2023;2:e000039. doi: 10.1136/bmjonc-2023-000039

Publication history

  • Received January 25, 2023
  • Accepted March 14, 2023
  • First published April 20, 2023.
Online issue publication 
April 20, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.